High expression of CRAM correlates with poor prognosis in patients with cervical carcinoma

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 3, 2014, Pages 1060-1068

  Hou, Teng ^a   Liang, Dongxia ^b   Yang, Dong ^b   He, Jiehua ^a   Huang, Yongwen ^a   Zhang, Yanna ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Atypical chemokine receptor; Cervical cancer; CRAM; Prognosis

Indexed keywords

CHEMOKINE RECEPTOR; DPYSL5 PROTEIN, HUMAN; NERVE PROTEIN; TUMOR MARKER;

ADULT; BIOSYNTHESIS; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NERVE TISSUE PROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CHEMOKINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84899582941     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Mantovani A, Bonecchi R and Locati M. Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol 2006; 6: 907-918.
2. Mantovani A, Savino B, Locati M, Zammataro L, Allavena P and Bonecchi R. The chemokine system in cancer biology and therapy. Cytokine Growth Factor Rev 2010; 21: 27-39.
3. Cancellieri C, Vacchini A, Locati M, Bonecchi R and Borroni EM. Atypical chemokine receptors: from silence to sound. Biochem Soc Trans 2013; 41: 231-236.
4. Hansell CA, Simpson CV and Nibbs RJ. Chemokine sequestration by atypical chemokine receptors. Biochem Soc Trans 2006; 34: 1009-1013.
5. Segerer S, Jedlicka J and Wuthrich RP. Atypical chemokine receptors in renal inflammation. Nephron Exp Nephrol 2010; 115: e89-95.
6. Catusse J, Leick M, Groch M, Clark DJ, Buchner MV, Zirlik K and Burger M. Role of the atypical chemoattractant receptor CRAM in regulating CCL19 induced CCR7 responses in B-cell chronic lymphocytic leukemia. Mol Cancer 2010; 9: 297.
7. Hartmann TN, Leick M, Ewers S, Diefenbacher A, Schraufstatter I, Honczarenko M and Burger M. Human B cells express the orphan chemokine receptor CRAM-A/B in a maturation-stage-dependent and CCL5-modulated manner. Immunology 2008; 125: 252-262.
8. Leick M, Catusse J, Follo M, Nibbs RJ, Hartmann TN, Veelken H and Burger M. CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B. Immunology 2010; 129: 536-546.
9. Zabel BA, Nakae S, Zuniga L, Kim JY, Ohyama T, Alt C, Pan J, Suto H, Soler D, Allen SJ, Handel TM, Song CH, Galli SJ and Butcher EC. Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. J Exp Med 2008; 205: 2207-2220.
10. Fan P, Kyaw H, Su K, Zeng Z, Augustus M, Carter KC and Li Y. Cloning and characterization of a novel human chemokine receptor. Biochem Biophys Res Commun 1998; 243: 264-268.
11. Zuurman MW, Heeroma J, Brouwer N, Boddeke HW and Biber K. LPS-induced expression of a novel chemokine receptor (L-CCR) in mouse glial cells in vitro and in vivo. Glia 2003; 41: 327-336.
12. Yin F, Xu Z, Wang Z, Yao H, Shen Z, Yu F, Tang Y, Fu D, Lin S, Lu G, Kung HF, Poon WS, Huang Y and Lin MC. Elevated chemokine CC-motif receptor-like 2 (CCRL2) promotes cell migration and invasion in glioblastoma. Biochem Biophys Res Commun 2012; 429: 168-172.
13. Hou T, Liang D, Xu L, Huang X, Huang Y and Zhang Y. Atypical chemokine receptors predict lymph node metastasis and prognosis in patients with cervical squamous cell cancer. Gynecol Oncol 2013; 130: 181-187.
14. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009; 105: 103-104.
15. Haie-Meder C, Morice P and Castiglione M. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21 Suppl 5: v37-40.
16. Colombo N, Carinelli S, Colombo A, Marini C, Rollo D and Sessa C. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012; 23 Suppl 7: vii27-32.
17. Barbera L and Thomas G. Management of early and locally advanced cervical cancer. Semin Oncol 2009; 36: 155-169.
18. Friedlander M and Grogan M. Guidelines for the treatment of recurrent and metastatic cervical cancer. Oncologist 2002; 7: 342-347.
19. Shimada T, Matsumoto M, Tatsumi Y, Kanamaru A and Akira S. A novel lipopolysaccharide inducible C-C chemokine receptor related gene in murine macrophages. FEBS Lett 1998; 425: 490-494.
20. Migeotte I, Franssen JD, Goriely S, Willems F and Parmentier M. Distribution and regulation of expression of the putative human chemokine receptor HCR in leukocyte populations. Eur J Immunol 2002; 32: 494-501.
21. Otero K, Vecchi A, Hirsch E, Kearley J, Vermi W, Del Prete A, Gonzalvo-Feo S, Garlanda C, Azzolino O, Salogni L, Lloyd CM, Facchetti F, Mantovani A and Sozzani S. Nonredundant role of CCRL2 in lung dendritic cell trafficking. Blood 2010; 116: 2942-2949.
22. Ulvmar MH, Hub E and Rot A. Atypical chemokine receptors. Exp Cell Res 2011; 317: 556-568.
23. Nibbs RJ, Gilchrist DS, King V, Ferra A, Forrow S, Hunter KD and Graham GJ. The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors. J Clin Invest 2007; 117: 1884-1892.
24. Shen H, Schuster R, Stringer KF, Waltz SE and Lentsch AB. The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth. FASEB J 2006; 20: 59-64.
25. Feng LY, Ou ZL, Wu FY, Shen ZZ and Shao ZM. Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival. Clin Cancer Res 2009; 15: 2962-2970.
26. Zeng XH, Ou ZL, Yu KD, Feng LY, Yin WJ, Li J, Shen ZZ and Shao ZM. Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes. Breast Cancer Res Treat 2011; 125: 715-727.
27. Lee KB, Lee JM, Park CY, Cho HY and Ha SY. What is the difference between squamous cell carcinoma and adenocarcinoma of the cervix? A matched case-control study. Int J Gynecol Cancer 2006; 16: 1569-1573.
28. Kleine W, Rau K, Schwoeorer D and Pfleiderer A. Prognosis of the adenocarcinoma of the cervix uteri: a comparative study. Gynecol Oncol 1989; 35: 145-149.